The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...
Gatos Silver, Inc. (NYSE:GATO) (TSX:GATO) ("Gatos Silver" or the "Company") today announced that Gatos Silver's stockholders have voted ...